Skip to main content
. Author manuscript; available in PMC: 2017 Sep 19.
Published in final edited form as: Cancer Detect Prev. 2005 Jan 28;29(1):59–65. doi: 10.1016/j.cdp.2004.10.002

Fig. 1.

Fig. 1

(A) Immunoblots of nuclear extracts from LSCC cells (HTB-182 human lung squamous cell carcinoma from the ATCC) probed with sera from LSCC patients and (B) with sera from subjects without cancer. Patient and control sera were diluted 1:500. Secondary antibody, sheep anti-human IgG, diluted 1:2500.